Viamet to Present at ICAAC/ICC 2015

Data Demonstrate Company’s Robust and Promising Antifungal Pipeline

September 10, 2015, Research Triangle Park, North Carolina – Viamet Pharmaceuticals, Inc. today announced that the company’s antifungal product pipeline will be the subject of five presentations at the 2015 American Society for Microbiology (ASM) Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and International Society of Chemotherapy (ISC) International Congress of Chemotherapy and Infection (ICC). The Conference will take place September 17-21, 2015 in San Diego, CA.